Stock listing

Frankfurt:3XV Xvivo Perfusion AB Aktie

German listing (Frankfurt) of Xvivo Perfusion AB · home listing Stockholm:XVIVO

Follow Xvivo Perfusion AB into a list and get an email when it puts out news.

Share price · FWB:3XV

€17.93 EUR -0.44 (-2.4%)

Close on Oct 27, 2026

Day range
€17.93 – €17.93 EUROct 27, 2026
Xvivo Perfusion AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:XVIVO · Home199.70 SEK-5.30 (-2.6%)83,785204.00205.00198.70205.00Close on Nov 2, 2026
LSE:0RKL202.20 SEK-7.00 (-3.3%)11,924202.20202.40199.20209.20Close on Oct 27, 2026
OTC:XVIPF$21.68 USD—250$21.68$21.68$21.68—Close on Oct 23, 2026
Frankfurt:3XV€17.93 EUR-0.44 (-2.4%)—€17.93€17.93€17.93€18.37Close on Oct 27, 2026
Ticker
Frankfurt:3XV
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Xvivo Perfusion (Stockholm:XVIVO) Q2 2026 Earnings Call

    Tue, Jul 14, 2026 · 7:00 AM ET

    Watch Transcript

  • Xvivo Perfusion (Stockholm:XVIVO) Q1 2026 Earnings Call

    Fri, Apr 24, 2026 · 9:00 AM ET

    Watch Transcript

  • Xvivo Perfusion (Stockholm:XVIVO) Q4 2025 Earnings Call

    Tue, Jan 27, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

XVIVO announces FDA receipt of PMA application for the XVIVO Heart Assist Transport System

Sep 28, 2026

XVIVO receives CE certificates for its groundbreaking heart preservation technology, transforming access to life-saving transplants across Europe

Aug 11, 2026

XVIVO granted additional patient enrollment in the US PRESERVE CAP study for XVIVO Heart Assist Transport

Aug 3, 2026

Interim Report January - June 2026

Jul 14, 2026

Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology

May 18, 2026

Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation

Apr 22, 2026

The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal

Apr 16, 2026

Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)

Mar 19, 2026

CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members

Feb 20, 2026

The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors

Feb 20, 2026

All Xvivo Perfusion AB news

Decks

Xvivo Perfusion AB on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
14 in the last 12 months · 23 in all · newest Sep 28, 2026 · oldest 2025
Calls
14 calls with a replay · 14 with a transcript · latest Jul 14, 2026
Decks
16 decks · latest Jul 14, 2026

Where Xvivo Perfusion AB is listed

ListingExchangeCountryCurrency
Stockholm:XVIVO · Home listingStockholmSwedenSEK
LSE:0RKLLSEUnited KingdomSEK
OTC:XVIPFOTCUnited StatesUSD
LS Exchange:A1J5GZLS ExchangeGermanyEUR
gettex:3XVgettexGermanyEUR
Lang & Schwarz:A1J5GZLang & SchwarzGermanyEUR
Stuttgart:3XVStuttgartGermanyEUR
Aquis:XVIVOSAquisUnited KingdomSEK
Frankfurt:3XV · This pageFrankfurtGermanyEUR
OTC:XVIPYOTCUnited StatesUSD
Aquis:XVIVOSAquisUnited KingdomSEK
Dusseldorf:3XVDusseldorfGermanyEUR
Munich:3XVMunichGermanyEUR
Turquoise:XVIVOSTurquoiseUnited KingdomSEK

Log in to ask 6ix AI your own questions about Xvivo Perfusion AB.